Brink's (BCO) Tops Q3 EPS by 7c; Provides FY19 Guidance

Brink's (NYSE: BCO) reported Q3 EPS of $0.91, $0.07 better than the analyst estimate of $0.84. Revenue for the quarter came in at $852 million versus the consensus estimate of $833.64 million.

GUIDANCE:

Brink's sees FY2019 EPS of $4.15-$4.35, versus the consensus of $4.72. Brink's sees FY2019 revenue of $3.8 billion, versus the consensus of $3.88 billion.

For earnings history and earnings-related data on Brink's (BCO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c